The Journal of Thoracic and Cardiovascular Surgery
Volume 140, Issue 2 , Pages 313-316 , August 2010

Clinical experience with the second-generation 3f Enable sutureless aortic valve prosthesis

  • Thierry Aymard, MD

      Affiliations

    • Department of Cardiovascular Surgery, University Hospital Berne, Berne, Switzerland
    • ,
  • Alexander Kadner, MD

      Affiliations

    • Department of Cardiovascular Surgery, University Hospital Berne, Berne, Switzerland
    • ,
  • Nazan Walpoth, MD

      Affiliations

    • Department of Cardiology, University Hospital Berne, Berne, Switzerland
    • ,
  • Volkhart Göber, MD

      Affiliations

    • Department of Cardiovascular Surgery, University Hospital Berne, Berne, Switzerland
    • ,
  • Lars Englberger, MD

      Affiliations

    • Department of Cardiovascular Surgery, University Hospital Berne, Berne, Switzerland
    • ,
  • Mario Stalder, MD

      Affiliations

    • Department of Cardiovascular Surgery, University Hospital Berne, Berne, Switzerland
    • ,
  • Friedrich Eckstein, MD

      Affiliations

    • Department of Cardiovascular Surgery, University Hospital Berne, Berne, Switzerland
    • ,
  • Claudia Zobrist, MD

      Affiliations

    • Institute of Anesthesiology, University Hospital Berne, Berne, Switzerland
    • ,
  • Thierry Carrel, MD

      Affiliations

    • Department of Cardiovascular Surgery, University Hospital Berne, Berne, Switzerland
    • Corresponding Author InformationAddress for reprints: Thierry Carrel, MD, Professor and Chairman, Department of Cardiovascular Surgery, University Hospital Berne, CH-3010 Berne, Switzerland.

Received 13 August 2009 ,Revised 24 September 2009 ,Accepted 15 October 2009.

References 

  1. Kvidal P, Bergström R, Hörte LG, Ståhle SR. Observed and relative survival after aortic valve replacement. J Am Coll Cardiol. 2000;35:747–756
  2. Magovern GJ, Cromie HW. Sutureless prosthetic heart valves. J Thorac Cardiovasc Surg. 1963;46:726–736
  3. Leyh R, Yildirim C, Buck T, Sommer S, Herold U, Jakob H. [Early single-center experience with the 3F-Enable aortic valve bioprosthesis]. Herz. 2006;31:423–428German
  4. Wendt D, Thielmann W, Buck T, Jánosi RA, Bossert T, Pizanis N, et al. First clinical experience and 1-year follow-up with the sutureless 3F-Enable aortic valve prosthesis. Eur J Cardiothorac Surg. 2008;33:542–547
  5. Martens S, Ploss A, Sirat S, Miskovic A, Moritz A, Doss M. Sutureless aortic valve replacement with the 3f Enable aortic bioprosthesis. Ann Thorac Surg. 2009;87:1914–1918
  6. Linneweber J, Kossagk C, Rogge ML, Dushe S, Dohmen P, Konertz W. Clinical experience with the 3F stentless aortic bioprosthesis: one-year follow up. J Heart Valve Dis. 2006;545–548
  7. Aymard T, Eckstein F, Englberger L, Stalder M, Kadner A, Carrel T. The Sorin Freedom SOLO stentless aortic valve: Technique of implantation and operative results in 109 patients. J Thorac Cardiovasc Surg. 2009;Epub 2009 Oct 7
  8. Bloomstein LZ, Gielchinsky I, Bernstein AD, Parsonnet V, Saunders C, Karanam R, et al. Aortic valve replacement in geriatric patients: determinants of in-hospital mortality. Ann Thorac Surg. 2001;71:597–600

 Disclosures: T. Carrel reports lecture fees from ATS and Edwards.

 3f Enable is manufactured by ATS Medical, Inc, Minneapolis, Minn.

PII: S0022-5223(09)01408-1

doi: 10.1016/j.jtcvs.2009.10.041

The Journal of Thoracic and Cardiovascular Surgery
Volume 140, Issue 2 , Pages 313-316 , August 2010

Article Tools

* Image Usage & Resolution